Johnson & Johnson's 2019 earnings call reveals strong operational growth across all segments, exceeding guidance.  Management expresses confidence in the company's ability to maintain above-market growth in 2020, driven by new product launches and continued investment in R&D.  The call highlights the ongoing focus on profitability in consumer health and emphasizes the potential of digital surgery and robotic technologies in medical devices.
[1]
